Help us: Donate
Follow us on:
×

Tag: Fundraising

GR15
Gitcoin has launched its 15th funding round and is again supporting projects focused on aging and rejuvenation. An alternative way to fund science Gitcoin is a platform focused on supporting the development of open-source Web3 software. This is a decentralized system based on blockchain technology with the goal of funding "public good" projects that are...
Crowd Funded Cures
We have written extensively about VitaDAO, a collective dedicated to community-governed, decentralized drug development. Probably the fastest and cheapest way to get geroprotective drugs to the market is by repurposing existing drugs, such as rapamycin, metformin, and acarbose. These drugs cost next to nothing, have a known safety record, and have shown a lot of...
GR13
Gitcoin has launched its 13th funding round and is again supporting projects focused on aging and rejuvenation. Visit the VitaDAO website to learn how you can get involved. The new funding round includes longevity research Gitcoin is a platform focused on supporting the development of open-source Web3 software. This is a decentralized system based on...
Blockchain
93% of the world's money is now digital, held in virtual ledgers across banks and other financial institutions. With the increasing digitalization of financial services, there is no doubt that we are heading for a cashless future; the only question is what that future will look like. The next step appears to be decentralization. In...
Gitcoin
Gitcoin is a platform dedicated to supporting the development of open-source Web3 software - decentralized architecture based upon blockchain technology - and the funding of  "public goods" projects that are intended to benefit everyone. Of course, one such public good is the extension of healthy human lifespan, and accordingly, in its 12th funding round, the...
PEARL Rapamycin Campaign
Today is an exciting day for us with the launch of the Participatory Evaluation (of) Aging (with) Rapamycin (for) Longevity Study, or PEARL, on Lifespan.io. The PEARL trial will be the first large-scale human trial with a focus on slowing down aging. Making clinical trials for anti-aging a reality Progress in developing effective interventions against...

Want the latest longevity news? Subscribe to our Newsletter!